tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Cytokinetics (CYTK)
NASDAQ:CYTK
CYTK
Cytokinetics
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding CYTK?
Track your performance easily
Link Broker

Cytokinetics (CYTK) Stock News & Sentiment

999 Followers
Bayer Secures Deal for Cytokinetics’ Heart Drug in Japan
Premium
Market News
Bayer Secures Deal for Cytokinetics’ Heart Drug in Japan
1M ago
CYTK
Cytokinetics’ Q3 2024: Progress and Financial Insights
Premium
Company Announcements
Cytokinetics’ Q3 2024: Progress and Financial Insights
2M ago
CYTK
Cytokinetics (CYTK) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Cytokinetics (CYTK) Q3 Earnings Cheat Sheet
2M ago
CYTK
Cytokinetics Names Brett Pletcher EVP and Chief Legal Officer
Premium
Company Announcements
Cytokinetics Names Brett Pletcher EVP and Chief Legal Officer
4M ago
8K
CYTK
Options Volatility and Implied Earnings Moves Today, August 09, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 09, 2024
4M ago
AQN
AXL
CYTK Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CYTK Earnings this Week: How Will it Perform?
5M ago
CYTK
Cytokinetics CEO Discusses Future Strategies at Conference
Premium
Company Announcements
Cytokinetics CEO Discusses Future Strategies at Conference
7M ago
8K
CYTK
More CYTK News >

CYTK News on the Web

Sanofi To Buy Rights To Develop Cytokinetics' Aficamten In Greater China From Corxel
rttnews
Neutral
Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?
Zacks
Neutral
FDA Accepts Cytokinetics' Application for Cardiovascular Drug
Zacks
Neutral
Optimistic Outlook for Cytokinetics Amidst Promising Aficamten Developments and Regulatory Progress
TipRanks News
Bullish
Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date
BioPharma Dive
Neutral
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Zacks
Neutral
Cytokinetics partnership demonstrates value of aficamten, says JMP Securities
The Fly
Neutral
Cytokinetics Secures Strategic Licensing Deal with Bayer, Boosting Global Prospects for Aficamten
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CYTK
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average65%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CYTK’s Media Buzz Sentiment?
1 articles about CYTK were published this week. In an average week, 1.5 articles are published.
    What is CYTK’s weekly average amount of articles?
    In an average week, 1.5 articles about CYTK are published.
      What is CYTK’s News Sentiment?
      50% of articles about CYTK were positive this week, compared to its sector average of 65%.
        Healthcare Stocks that are Trending in the News
        VRDNViridian Therapeutics
        ANNXAnnexon Biosciences
        LRMRLarimar Therapeutics
        MCKMcKesson
        TEVATeva Pharmaceutical
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing